Eva Y -h P Lee

Title: The Innovations of Eva Y-h P Lee

Introduction

Eva Y-h P Lee is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of cancer research, particularly through her work on the retinoblastoma susceptibility gene. Her innovative approach has led to advancements in diagnosing and treating cancers associated with this gene.

Latest Patents

Eva Y-h P Lee holds a patent for ppRB.sup.110, a nuclear phosphoprotein product of the retinoblastoma susceptibility gene. This invention relates to a phosphoprotein primarily located in the cell nucleus, which exhibits DNA binding activity. The patent also details the amino acid sequence of the phosphoprotein and includes a specific purified anti-retinoblastoma phosphoprotein antibody. Furthermore, it outlines a method for diagnosing retinoblastoma and other cancers linked to the retinoblastoma gene, as well as strategies for treating these cancers and regulating the oncogenicity of other genes. She has 1 patent to her name.

Career Highlights

Eva Y-h P Lee is affiliated with the University of California, where she continues her research and innovation in the field of molecular biology and cancer genetics. Her work has garnered attention for its potential impact on cancer diagnosis and treatment.

Collaborations

One of her notable collaborators is Wen-Hwa Lee, with whom she has worked closely on various research projects. Their combined expertise has contributed to advancements in understanding the mechanisms of cancer.

Conclusion

Eva Y-h P Lee's contributions to cancer research through her innovative patent and collaborations highlight her role as a leading inventor in the field. Her work continues to pave the way for new diagnostic and therapeutic strategies in oncology.